CYTOSAR Powder for solution for injection Ref.[50441] Active ingredients: Cytarabine

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2021  Publisher: Pfizer Laboratories (Pty) Ltd, 85 Bute Lane, Sandton 2196, South Africa Tel: +27(0)11 320 6000 / 0860 734 937 (Toll-free South Africa)

Product name and form

CYTOSAR 100 mg Powder for solution for injection.

CYTOSAR 500 mg Powder for solution for injection.

Bacteriostatic water for injection plus benzyl alcohol 0,9% m/v.

Pharmaceutical Form

Powder for solution for injection.

CYTOSAR is available as a freeze-dried preparation.

Qualitative and quantitative composition

CYTOSAR 100 mg contains 100 mg cytarabine per vial.

CYTOSAR 500 mg contains 500 mg cytarabine per vial.

CYTOSAR is packed with Bacteriostatic water for injection plus benzyl alcohol 0,9% m/v and must be reconstituted before use.

Sugar free.

Excipients with known effect:

One 5 mL ampoule of Bacteriostatic water for injection plus benzyl alcohol 0,9% m/v contains 45 mg benzyl alcohol.

One 10 mL ampoule of Bacteriostatic water for injection plus benzyl alcohol 0,9% m/v contains 90 mg benzyl alcohol.

DO NOT USE THIS DILUENT CONTAINING BENZYL ALCOHOL FOR INTRATHECAL USE OR FOR HIGH DOSE THERAPY (see sections 4.3, 4.4 and 4.2).

For the full list of excipients, see section 6.1.

Active Ingredient Description
Cytarabine

Cytarabine (ARA-C) is metabolised in vivo to ARA-CTP phosphorylated compound. This competitively inhibits DNA polymerase and may also inhibit certain acid kinase enzymes.

List of Excipients

CYTOSAR 100 mg and 500 mg:

Hydrochloric acid for pH adjustment
Sodium hydroxide for pH adjustment
Bacteriostatic water for injection plus benzyl alcohol 0,9% m/v
Water for injection
Benzyl alcohol (0,9% m/v)

Pack sizes and marketing

CYTOSAR 100 mg: 100 mg vial plus 5 mL water for injection (with benzyl alcohol 0,9% m/v).

CYTOSAR 500 mg: 500 mg vial plus 10 mL water for injection (with benzyl alcohol 0,9% m/v).

CYTOSAR 100 mg and 500 mg are in multidose vials.

Bacteriostatic water for injection plus benzyl alcohol 0,9% m/v is available in ampoules of 5 mL and 10 mL.

Not all pack sizes may be marketed.

Marketing authorization holder

Pfizer Laboratories (Pty) Ltd, 85 Bute Lane, Sandton 2196, South Africa
Tel: +27(0)11 320 6000 / 0860 734 937 (Toll-free South Africa)

Marketing authorization dates and numbers

CYTOSTAR 100 mg: H2757 (Act 101/1965)

CYTOSTAR 500 mg: T/26/47

Bacteriostatic water for injection plus benzyl alcohol 0,9% m/v: H/34/60

CYTOSAR 100 mg: N/A (Old medicine)

CYTOSAR 500 mg: 18 November 1987

Bacteriostatic water for injection plus benzyl alcohol 0,9% m/v: 20 October 1975

Drugs

Drug Countries
CYTOSAR Estonia, Hong Kong, Croatia, Mexico, Poland, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.